نيلوتينيب (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "نيلوتينيب" in Arabic language version.

refsWebsite

Global rank Arabic rank

1^st place

2^nd place

5^th place

43^rd place

2^nd place

1,684^th place

1,025^th place

399^th place

241^st place

5^th place

4^th place

719^th place

243^rd place

cancer.gov

"Nilotinib". National Cancer Institute (بالإنجليزية). 1 Feb 2008. Archived from the original on 2021-07-14. Retrieved 2019-11-14.
"Nilotinib". National Cancer Institute (بالإنجليزية). 1 Feb 2008. Archived from the original on 2021-07-14. Retrieved 2019-11-14.

Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. QID:Q123478206.
Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002

"Nilotinib Monograph for Professionals". Drugs.com (بالإنجليزية). Archived from the original on 2021-07-14. Retrieved 2019-11-14.
"Nilotinib Monograph for Professionals". Drugs.com (بالإنجليزية). Archived from the original on 2021-07-14. Retrieved 2019-11-14.

"Tasigna (nilotinib) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. مؤرشف من الأصل في 2021-07-17. اطلع عليه بتاريخ 2014-01-25.

"Tasigna (nilotinib) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. مؤرشف من الأصل في 2021-07-17. اطلع عليه بتاريخ 2014-01-25.
"Nilotinib". National Cancer Institute (بالإنجليزية). 1 Feb 2008. Archived from the original on 2021-07-14. Retrieved 2019-11-14.
"Nilotinib". National Cancer Institute (بالإنجليزية). 1 Feb 2008. Archived from the original on 2021-07-14. Retrieved 2019-11-14.
"Nilotinib Monograph for Professionals". Drugs.com (بالإنجليزية). Archived from the original on 2021-07-14. Retrieved 2019-11-14.
"Nilotinib Monograph for Professionals". Drugs.com (بالإنجليزية). Archived from the original on 2021-07-14. Retrieved 2019-11-14.

Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. QID:Q123478206.
Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002

Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. QID:Q123478206.